Orchard Therapeutics Highlights 2020 Strategic Priorities

NEXT STORY
Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance
PREV STORY
Retrophin Provides Corporate Update and 2020 Outlook
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results

ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study Data

NEW YORK, July 05, 2017 (GLOBE NEWSWIRE) -- ILiAD Biotechnologies, LLC (ILiAD), a clinical ...

author_avatar
NASDAQ Market News

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE’s potential to achieve ...

author_avatar
NASDAQ Market News